ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy?

Core Viewpoint - ADC Therapeutics SA (ADCT) is identified as a strong momentum stock with a Momentum Style Score of A and a Zacks Rank of 2 (Buy), indicating potential for significant near-term gains [3][4][12]. Momentum Indicators - ADCT shares have increased by 28.57% over the past week, while the Zacks Medical - Biomedical and Genetics industry has remained flat during the same period [6]. - Over the last quarter, ADCT shares rose by 23.68%, and they have surged 123.81% over the past year, significantly outperforming the S&P 500, which increased by only 4% and 14.09% respectively [7]. Trading Volume - The average 20-day trading volume for ADCT is 1,634,451 shares, which serves as a bullish indicator when combined with rising stock prices [8]. Earnings Outlook - In the past two months, two earnings estimates for ADCT have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from -$1.68 to -$1.47 [10]. - For the next fiscal year, one estimate has moved upwards with no downward revisions, indicating a positive earnings outlook [10].